CNSL.L

Cambridge Nutritional Sciences
Cambridge Nutrition. - Notice of Results and Investor Presentation
15th November 2024, 09:24
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4304M
Cambridge Nutritional Sciences PLC
15 November 2024
 

15 November 2024

 

Cambridge Nutritional Sciences plc

 

(the "Company" or "CNSL")

 

Notice of Results and Investor Presentation

 

Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will issue its Half Year results for the six months ended 30 September 2023 on Thursday 21 November 2024.

 

Investor presentation

There will be a live presentation relating to the Half Year Results via the Investor Meet Company platform on Thursday 21 November 2024 at 16:00 GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 20 Nov 2024, 09:00 GMT, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Cambridge Nutritional Sciences plc via:

 

https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor

 

Investors who already follow Cambridge Nutritional Sciences plc on the Investor Meet Company platform will automatically be invited.

 

 

 

Contacts: 

Cambridge Nutritional Sciences plc        

www.cnsplc.com

Carolyn Rand, Executive Chair

investors@cnsplc.com 

James Cooper, Interim Chief Executive


Cavendish Capital Markets Limited    

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)






About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFFDSUIELSEEF]]>
TwitterFacebookLinkedIn